Cytarabine 71288-0169
Product NDC
71288-0169- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 28, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA208485
Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cytarabine | 20 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (71288-169-25) / 25 mL in 1 VIAL, MULTI-DOSE